Literature DB >> 35155024

Rhinocerebral Mucormycosis With Brain Abscess Presenting as Status Epileptucus in a COVID-19-Infected Male: A Calamitous Complication.

Vinay Verma1, Sourya Acharya1, Sunil Kumar1, Shilpa A Gaidhane2, Utkarsh Thatere1.   

Abstract

With the evolution of COVID-19 disease, the emergence of more complications associated with COVID-19 is taking place. Mucormycosis is the most common opportunistic fungal infection encountered after COVID-19. In this case report, we describe a case of a 61-year-old male type 2 diabetic with sino-orbital-cerebral mucormycosis infection who was treated with conventional guidelines for a recent COVID-19 infection and further presented with generalized tonic-clonic status seizures. Neuroimaging revealed sino-orbital mucormycosis with right frontal lobe abscess. He was treated with anti-epileptics, steroids, amphotericin-B, and functional endoscopic sinus surgery (FESS).
Copyright © 2022, Verma et al.

Entities:  

Keywords:  brain abscess; cerebral mucormycosis; covid 19; fess; seizure; status epilepticus

Year:  2022        PMID: 35155024      PMCID: PMC8825442          DOI: 10.7759/cureus.21061

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

Review 1.  Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Authors:  Oliver A Cornely; Ana Alastruey-Izquierdo; Dorothee Arenz; Sharon C A Chen; Eric Dannaoui; Bruno Hochhegger; Martin Hoenigl; Henrik E Jensen; Katrien Lagrou; Russell E Lewis; Sibylle C Mellinghoff; Mervyn Mer; Zoi D Pana; Danila Seidel; Donald C Sheppard; Roger Wahba; Murat Akova; Alexandre Alanio; Abdullah M S Al-Hatmi; Sevtap Arikan-Akdagli; Hamid Badali; Ronen Ben-Ami; Alexandro Bonifaz; Stéphane Bretagne; Elio Castagnola; Methee Chayakulkeeree; Arnaldo L Colombo; Dora E Corzo-León; Lubos Drgona; Andreas H Groll; Jesus Guinea; Claus-Peter Heussel; Ashraf S Ibrahim; Souha S Kanj; Nikolay Klimko; Michaela Lackner; Frederic Lamoth; Fanny Lanternier; Cornelia Lass-Floerl; Dong-Gun Lee; Thomas Lehrnbecher; Badre E Lmimouni; Mihai Mares; Georg Maschmeyer; Jacques F Meis; Joseph Meletiadis; C Orla Morrissey; Marcio Nucci; Rita Oladele; Livio Pagano; Alessandro Pasqualotto; Atul Patel; Zdenek Racil; Malcolm Richardson; Emmanuel Roilides; Markus Ruhnke; Seyedmojtaba Seyedmousavi; Neeraj Sidharthan; Nina Singh; János Sinko; Anna Skiada; Monica Slavin; Rajeev Soman; Brad Spellberg; William Steinbach; Ban Hock Tan; Andrew J Ullmann; Jörg J Vehreschild; Maria J G T Vehreschild; Thomas J Walsh; P Lewis White; Nathan P Wiederhold; Theoklis Zaoutis; Arunaloke Chakrabarti
Journal:  Lancet Infect Dis       Date:  2019-11-05       Impact factor: 25.071

2.  Sino-orbital mucormycosis in a COVID-19 patient: A case report.

Authors:  Aastha Maini; Gaurav Tomar; Deepak Khanna; Yogesh Kini; Hardik Mehta; V Bhagyasree
Journal:  Int J Surg Case Rep       Date:  2021-05-04

3.  Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.

Authors:  S Sharma; M Grover; S Bhargava; S Samdani; T Kataria
Journal:  J Laryngol Otol       Date:  2021-04-08       Impact factor: 1.469

4.  COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?

Authors:  Shweta Mallikarjun Revannavar; Supriya P S; Laxminarayana Samaga; Vineeth V K
Journal:  BMJ Case Rep       Date:  2021-04-27

5.  Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?

Authors:  Akshay Raut; Nguyen Tien Huy
Journal:  Lancet Respir Med       Date:  2021-06-03       Impact factor: 30.700

6.  Risks and features of secondary infections in severe and critical ill COVID-19 patients.

Authors:  Haocheng Zhang; Yi Zhang; Jing Wu; Yang Li; Xian Zhou; Xin Li; Haili Chen; Mingquan Guo; Shu Chen; Feng Sun; Richeng Mao; Chao Qiu; Zhaoqin Zhu; Jingwen Ai; Wenhong Zhang
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

7.  Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.

Authors:  Amirreza Veisi; Abbas Bagheri; Mohammad Eshaghi; Mohamad Hasan Rikhtehgar; Mozhgan Rezaei Kanavi; Reza Farjad
Journal:  Eur J Ophthalmol       Date:  2021-04-10       Impact factor: 1.922

  9 in total
  2 in total

1.  Comparative risk assessment of COVID-19 associated mucormycosis and aspergillosis: A systematic review.

Authors:  Prodip Kumar Baral; Md Abdul Aziz; Mohammad Safiqul Islam
Journal:  Health Sci Rep       Date:  2022-08-18

2.  Surgical management of post-COVID invasive rhino-orbito-cerebral mucormycosis and its outcomes: Role of neurosurgeons in a tertiary care center.

Authors:  Anand Kumar Das; Suraj Kant Mani; Saraj Kumar Singh
Journal:  Surg Neurol Int       Date:  2022-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.